Table 3. Transition probabilities and hazard coefficients related to loss to follow-up.

Variables	Transition probabilities and hazard coefficients (95%) per 1 month cycle
	Public-care			Private-care
Transitions within ART model
Transition probability to LTFU within 0–6 months on ART
On starting ART		0,0085 (0,0080 to 0,0091)		0,0006 (0,0006 to 0,0006)
On restarting ART		0,0270 (0,0205 to 0,0356)		0,0251 (0,0251 to 0,0251)
Hazard coefficient to LTFU within >6 months on ART
CD4 0–49 cells/µL	VL <1,000 copies/ml	−4,7		−5,13
CD4 0–49 cells/µL	VL 1,000–100,000 copies/ml	−3,79		−4,16
CD4 0–49 cells/µL	VL >100,000 copies/ml	−4,00		−4,37
CD4 50–199 cells/µL	VL <1,000 copies/ml	−5,31		−5,44
CD4 50–199 cells/µL	VL 1,000–100,000 copies/ml	−4,4		−4,47
CD4 50–199 cells/µL	VL <1000 copies/ml	−4,61		−4,68
CD4 200–349 cells/µL	VL >100,000 copies/ml	−5,73		−4,52
CD4 200–349 cells/µL	VL 1,000–100,000 copies/ml	−4,82		−3,56
CD4 200–349 cells/µL	VL <1000 copies/ml	−5,03		−3,76
CD4 350–499 cells/µL	VL >100,000 copies/ml	−5,73		−4,52
CD4 350–499 cells/µL	VL 1,000–100,000 copies/ml	−4,82		−3,56
CD4 350–499 cells/µL	VL >100,000 copies/ml	−5,03		−3,76
CD4 ≥500 cells/µL	VL <1,000 copies/ml	−5,73		−4,52
CD4 ≥500 cells/µL	VL 1,000–100,000 copies/ml	−4,82		−3,56
CD4 ≥500 cells/µL	VL >100,000 copies/ml	−5,03		−3,76
Hazard coefficients for Gompertz function
alpha			1,5	0,5
beta – half-life (months)			12	8
Initial distribution within LTFU model
CD4 0–49 cells/µL			0,278 (0,255 to 0,302)	0,243 (0,217 to 0,269)
CD4 50–199 cells/µL			0,722 (0,745 to 0,698)	0,757 (0,783 to 0,731)
Transitions within LTFU model
Transition probability between CD4 category
CD4 50–199 to CD4 0–49 cells/µL			0,005 (0,005 to 0,005)	0,006 (0,006 to 0,006)
Transition probability back to ART
CD4 0–199 cells/µL			0,134 (0,128 to 0,141)	0,146 (0,139 to 0,154)
Transition probability to death
CD4 0–49 cells/µL			0,006 (0,005 to 0,008)	0,006 (0,005 to 0,008)
CD4 50–199 cells/µL			0,001 (0,001 to 0,017)	0,001 (0,001 to 0,017)